The Association of Metabolomic Profiles of a Healthy Lifestyle with Heart Failure Risk in a Prospective Study

Lifestyle has been linked to the incidence of heart failure, but the underlying biological mechanisms remain unclear. Using the metabolomic, lifestyle, and heart failure data of the UK Biobank, we identified and validated healthy lifestyle-related metabolites in a matched case-control and cohort study, respectively. We then evaluated the association of healthy lifestyle-related metabolites with heart failure (HF) risk and the added predictivity of these healthy lifestyle-associated metabolites for HF. Of 161 metabolites, 8 were identified to be significantly related to healthy lifestyle. Notably, omega-3 fatty acids and docosahexaenoic acid (DHA) positively associated with a healthy lifestyle score (HLS) and exhibited a negative association with heart failure risk. Conversely, creatinine negatively associated with a HLS, but was positively correlated with the risk of HF. Adding these three metabolites to the classical risk factor prediction model, the prediction accuracy of heart failure incidence can be improved as assessed by the C-statistic (increasing from 0.806 [95% CI, 0.796–0.816] to 0.844 [95% CI, 0.834–0.854], p-value < 0.001). A healthy lifestyle is associated with significant metabolic alterations, among which metabolites related to healthy lifestyle may be critical for the relationship between healthy lifestyle and HF. Healthy lifestyle-related metabolites might enhance HF prediction, but additional validation studies are necessary.

[1]  E. Benjamin,et al.  Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study , 2023, Journal of the American Heart Association.

[2]  M. Link,et al.  2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2022, Circulation.

[3]  M. Scholz,et al.  Whole Blood Metabolite Profiles Reflect Changes in Energy Metabolism in Heart Failure , 2022, Metabolites.

[4]  F. Rodríguez‐Artalejo,et al.  Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain , 2022, International Journal of Behavioral Nutrition and Physical Activity.

[5]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[6]  L. Snetselaar,et al.  Dietary Guidelines for Americans, 2020–2025 , 2021, Nutrition today.

[7]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[8]  Hongbing Shen,et al.  Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle , 2021, Cancer Research.

[9]  J. Phillips.  Dietary Guidelines for Americans, 2020–2025 , 2021, Workplace health & safety.

[10]  J. Manson,et al.  Omega-3 supplementation and heart failure: A meta-analysis of 12 trials including 81,364 participants. , 2021, Contemporary clinical trials.

[11]  B. Molitoris,et al.  Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure , 2021, ESC heart failure.

[12]  O. Franco,et al.  Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies , 2021, BMJ.

[13]  J. Manson,et al.  Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. , 2021, JAMA.

[14]  L. Liang,et al.  Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease , 2021, eLife.

[15]  M. Ueeda,et al.  High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction , 2021, Nutrients.

[16]  E. Kim,et al.  Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation , 2020, Antioxidants.

[17]  Morten Wang Fagerland,et al.  Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial. , 2020, Circulation.

[18]  D. Mozaffarian,et al.  Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. , 2020, JAMA.

[19]  Molly A. Hall,et al.  Semi-automated NMR Pipeline for Environmental Exposures: New Insights on the Metabolomics of Smokers versus Non-smokers , 2020, PSB.

[20]  O. Ilkayeva,et al.  Nutritional modulation of heart failure in mitochondrial pyruvate carrier–deficient mice , 2020, Nature Metabolism.

[21]  L. Liang,et al.  Metabolomic Signatures of Long-term Coffee Consumption and Risk of Type 2 Diabetes in Women , 2020, Diabetes Care.

[22]  Richard T. Lee,et al.  Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice , 2020, Aging cell.

[23]  T. Littlejohns,et al.  Association of Lifestyle and Genetic Risk With Incidence of Dementia. , 2019, JAMA.

[24]  K. Aonuma,et al.  Exercise training reduces ventricular arrhythmias through restoring calcium handling and sympathetic tone in myocardial infarction mice , 2019, Physiological reports.

[25]  T. Lehtimäki,et al.  Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts , 2019, bioRxiv.

[26]  M. Tomczyk,et al.  A Comprehensive Review of Chemistry, Sources and Bioavailability of Omega-3 Fatty Acids , 2018, Nutrients.

[27]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[28]  Pim van der Harst,et al.  Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study , 2018, JAMA cardiology.

[29]  V. Viallon,et al.  Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort. , 2018, The American journal of clinical nutrition.

[30]  P. Ponikowski,et al.  Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data , 2018, Circulation. Heart failure.

[31]  F. Shahidi,et al.  Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. , 2018, Annual review of food science and technology.

[32]  I. Mavelli,et al.  Exercise training in Tgαq*44 mice during the progression of chronic heart failure: cardiac vs. peripheral (soleus muscle) impairments to oxidative metabolism. , 2017, Journal of applied physiology.

[33]  Bin Wang,et al.  Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation , 2017, PloS one.

[34]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[35]  Rachel Gibson,et al.  Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial , 2017, The lancet. Diabetes & endocrinology.

[36]  T. O’Connell,et al.  ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4. , 2017, Journal of molecular and cellular cardiology.

[37]  S. Mayne,et al.  Identifying biomarkers of dietary patterns by using metabolomics. , 2017, The American journal of clinical nutrition.

[38]  W. Chow,et al.  Metabolomics‐identified metabolites associated with body mass index and prospective weight gain among Mexican American women , 2016, Obesity science & practice.

[39]  S. Larsson,et al.  Healthy Lifestyle and Risk of Heart Failure: Results From 2 Prospective Cohort Studies. , 2016, Circulation. Heart failure.

[40]  T. Lehtimäki,et al.  Metabolic profiling of alcohol consumption in 9778 young adults , 2016, bioRxiv.

[41]  S. Frantz,et al.  Pathophysiology of Heart Failure. , 2015, Comprehensive Physiology.

[42]  D. Mozaffarian,et al.  Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults , 2015, JACC. Heart failure.

[43]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[44]  J. Manson,et al.  Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study. , 2014, Journal of the American College of Cardiology.

[45]  G. Okoye,et al.  Therapeutic effect of continuous exercise training program on serum creatinine concentration in men with hypertension: a randomized controlled trial. , 2014, Ghana medical journal.

[46]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[47]  P. O’Reilly,et al.  Long-term Leisure-time Physical Activity and Serum Metabolome , 2013, Circulation.

[48]  J. Gaziano,et al.  Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians' Health Study. , 2012, The American journal of clinical nutrition.

[49]  William E. Kraus,et al.  Metabolomic Profiling for the Identification of Novel Biomarkers and Mechanisms Related to Common Cardiovascular Diseases: Form and Function , 2012, Circulation.

[50]  J. Tuomilehto,et al.  Lifestyle Factors in Relation to Heart Failure Among Finnish Men and Women , 2011, Circulation. Heart failure.

[51]  V. Feigin,et al.  Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? , 2009, Heart.

[52]  J. Haselden,et al.  Metabolic Profiling as a Tool for Understanding Mechanisms of Toxicity , 2008, Toxicologic pathology.

[53]  L. Lerman,et al.  Smoking Is Associated With Epicardial Coronary Endothelial Dysfunction and Elevated White Blood Cell Count in Patients With Chest Pain and Early Coronary Artery Disease , 2007, Circulation.

[54]  M. Fishbein,et al.  Smoking Increases Inflammation and Metalloproteinase Expression in Human Carotid Atherosclerotic Plaques , 2004, Journal of cardiovascular pharmacology and therapeutics.

[55]  Royston Goodacre,et al.  Metabolic profiling: pathways in discovery. , 2004, Drug discovery today.

[56]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[57]  M. Piano.  Alcohol and heart failure. , 2002, Journal of cardiac failure.

[58]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[59]  M. Adams,et al.  Metoprolol suppresses the development of ethanol-induced cardiac hypertrophy in the rat. , 1990, Canadian journal of physiology and pharmacology.

[60]  C. Angermann,et al.  The omega-3 index in patients with heart failure: A prospective cohort study. , 2019, Prostaglandins, leukotrienes, and essential fatty acids.

[61]  T. Minamino,et al.  Metabolomic Analysis in Heart Failure. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[62]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[63]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .